BN Business News
Add your company to Business Communicator →

Business · 16/08/2023

FDA Announces Final Guidance on Informed Consent for Clinical Investigations

The US Food and Drug Administration (FDA) has released a final guidance document to help Institutional Review Boards, Clinical Investigators, and Sponsors ensure informed consent for human subjects in clinical trials of FDA-regulated products, replacing a 1998 and 2014 draft guidance.

Original source language: Federal Register — Food and Drug AdministrationOpen original release →

Explore insights